1402
S. Alper-Hayta et al. / European Journal of Medicinal Chemistry 41 (2006) 1398e1404
crystals [27]. Then the general synthetic procedure as seen
above was employed. Quantitative reduction of nitro group
in compound 11 was achieved by catalytic hydrogenation to
make compound 12. Compound 11 (3.5 mmol) in EtOH
(75 ml) was subjected to hydrogenation using 40 psi of H2
and 10% PdeC (40 mg) until uptake of H2 ceased. The cata-
lyst was filtered on a bed of celite, washed with EtOH, and the
filtrate was concentrated in vacuo to give compound 12 [28].
8.30 (s, 1H, NH ); IR (cmꢂ1): 3200e2900, 1740e1690,
1613, 1550e1510, 1440e1320, 1260e1030, 990e730; MS
(70 eV) m/z: 280 (Mþ), 42 (100%).
4.2.6. 3,4-Dihydro-3-oxo-7-amino-2H-1,4-benzoxazine-2-
acetate (12)
C12H14N2O4 e m.p.: 150 ꢁC; yield (%): 35; 1H NMR
(ppm): 1.25 (t, 3H, CH2COOCH2CH3, J ¼ 7.2), 3.00 (dd,
2H, CH2COOCH2CH3), 3.50 (s, 2H, NH2), 4.20 (q, 2H,
CH2COOCH2CH3), 5.00 (q, 1H, CH ), 6.20e6.50 (m, 3H, ar-
omatic H, Jm ¼ 8.3), 7.60 (s, 1H, NH ); IR (cmꢂ1): 3400e
2800, 1733e1682, 1523, 1375, 1278e1050, 855e439; MS
(70 eV) m/z: 250 (Mþ), 83 (100%).
4.2.1. 3,4-Dihydro-3-oxo-2H-1,4-benzoxazine-2-acetate (7)
C12H13NO4 e m.p.: 106e107 ꢁC [22]; yield (%): 80;
1H NMR (ppm): 1.25 (t, 3H, CH2COOCH2CH3, J ¼ 7.1), 3.00
(dd, 2H, CH2COOCH2CH3), 4.20 (q, 2H, CH2COOCH2CH3,
J ¼ 7.2), 5.00 (q, 1H, CH ), 6.80e7.10 (m, 4H, aromatic H ),
8.50 (s, 1H, NH ); IR (cmꢂ1): 3230e2860, 1740, 1695,
1625, 1520, 1480e1280, 1240e1030, 950e585; MS (70 eV)
m/z: 235 (Mþ), 161 (100%).
4.2.7. 3,4-Dihydro-3-oxo-6-chloro-7-nitro-2H-1,4-
benzoxazine-2-acetate (13)
C12H11N2O6Cl e m.p.: 162e165 ꢁC [23]; yield (%): 50; 1H
NMR (ppm): 1.25 (t, 3H, CH2COOCH2CH3, J ¼ 7.2), 3.00
(dd, 2H, CH2COOCH2CH3), 4.10 (q, 2H, CH2COOCH2CH3,
J ¼ 7.1), 5.00 (q, 1H, CH ), 6.90 (s, 1H, 5-H ), 7.60 (s, 1H,
8-H ), 8.40 (s, 1H, NH ); IR (cmꢂ1): 3200e2900, 1740e
1690, 1615, 1550e1515, 1440e1319, 1250e1000, 950e
685; MS (70 eV) m/z: 314 (Mþ), 43 (100%).
4.2.2. 3,4-Dihydro-3-oxo-6-methyl-2H-1,4-benzoxazine-2-
acetate (8)
1
C13H15NO4 e m.p.: 115e116 ꢁC [22]; yield (%): 36; H
NMR (ppm): 1.25 (t, 3H, CH2COOCH2CH3, J ¼ 7.1), 2.25
(s, 3H, CH3), 2.80e3.00 (dd, 2H, CH2COOCH2CH3), 4.20
(q, 2H, CH2COOCH2CH3, J ¼ 7.1), 5.00 (q, 1H, CH ), 6.50
(d, 1H, 5-H, J5,7 ¼ 1.1), 6.75e6.85 (m, 2H, 7-H/8-H ), 8.10
(s, 1H, NH ); IR (cmꢂ1): 3220e2890, 1750, 1690, 1618,
1430e1500, 1460e1330, 1300e1035, 990e590; MS
(70 eV) m/z: 249 (Mþ), 42 (100%).
4.2.8. 3,4-Dihydro-3-oxo-4-methyl-2H-1,4-benzoxazine-
2-acetate (14)
1
C13H15NO4 e m.p.: 35 ꢁC; yield (%): 40; H NMR (ppm):
1.25 (t, 3H, CH2COOCH2CH3, J ¼ 7.1), 3.00 (dd, 2H,
CH2COOCH2CH3), 3.40 (s, 3H, CH3), 4.20 (q, 2H,
CH2COOCH2CH3, J ¼ 7.2), 5.00 (q, 1H, CH ), 7.10 (m, 4H,
5-H, 6-H, 7-H, 8-H ); IR (cmꢂ1): 1744e1683; MS (70 eV)
m/z: 249 (Mþ), 249 (100%).
4.2.3. 3,4-Dihydro-3-oxo-6-chloro-2H-1,4-benzoxazine-2-
acetate (9)
C12H12NO4Cl e m.p.: 143e145 ꢁC [22]; yield (%): 50; 1H
NMR (ppm): 1.25 (t, 3H, CH2COOCH2CH3, J ¼ 7.1), 3.00
(dd, 2H, CH2COOCH2CH3), 4.20 (q, 2H, CH2COOCH2CH3,
J ¼ 7.1), 4.95 (q, 1H, CH ), 6.75e6.95 (m, 3H, aromatic H ),
8.30 (s, 1H, NH ); IR (cmꢂ1): 3200e2895, 1740e1700,
1615, 1510, 1430e1330, 1300e1030, 990e590; MS (70 eV)
m/z: 269 (Mþ), 195 (100%).
4.2.9. 3,4-Dihydro-3-oxo-4,6-dimethyl-2H-1,4-benzoxazine-
2-acetate (15)
1
C14H17NO4 e m.p.: 58 ꢁC; yield (%): 45; H NMR (ppm):
1.30 (t, 3H, CH2COOCH2CH3, J ¼ 7.1), 2.30 (s, 3H, CH3),
3.00 (dd, 2H, CH2COOCH2CH3), 3.45 (s, 3H, CH3), 4.25 (q,
2H, CH2COOCH2CH3, J ¼ 7.1), 5.00 (q, 1H, CH ), 6.80 (m,
3H, 5-H, 7-H, 8-H ); IR (cmꢂ1): 1743e1691; MS (70 eV)
m/z: 263 (Mþ), 189 (100%).
4.2.4. 3,4-Dihydro-3-oxo-6-ethoxycarbonyl-2H-1,4-
benzoxazine-2-acetate (10)
1
C15H17NO6 e m.p.: 125e130 ꢁC; yield (%): 60; H NMR
(ppm): 1.15 (t, 3H, CH2COOCH2CH3, J ¼ 7.1), 1.30 (t, 3H,
COOCH2CH3, J ¼ 7.1), 3.00 (dd, 2H, CH2COOCH2CH3),
4.30 (q, 2H, CH2COOCH2CH3, J ¼ 7.1), 4.90 (q, 2H,
COOCH2CH3, J ¼ 7.1), 5.10 (q, 1H, CH ), 6.70e7.70 (q,
3H, aromatic H, J8,5 ¼ 8.5, J0 ¼ 2.0, J7,5 ¼ 8.5), 8.70 (s, 1H,
NH ); IR (cmꢂ1): 3200e2850, 1687, 1615, 1493, 1376,
1298e1132, 989e420; MS (70 eV) m/z: 308 (Mþ), 45
(100%).
4.2.10. 3,4-Dihydro-3-oxo-4-methyl-6-chloro-2H-1,4-
benzoxazine-2-acetate (16)
C13H14NO4Cl e m.p.: 56 ꢁC; yield (%): 41; 1H NMR
(ppm): 1.25 (t, 3H, CH2COOCH2CH3, J ¼ 7.1), 3.00 (dd,
2H, CH2COOCH2CH3), 3.40 (s, 3H, CH3), 4.20 (q, 2H,
CH2COOCH2CH3, J ¼ 7.1), 5.00 (q, 1H, CH ), 6.90 (m, 3H,
5-H, 7-H, 8-H ); IR (cmꢂ1): 1741e1692; MS (70 eV) m/z:
283 (Mþ), 82 (100%).
4.2.5. 3,4-Dihydro-3-oxo-7-nitro-2H-1,4-benzoxazine-2-
acetate (11)
4.2.11. 3,4-Dihydro-3-oxo-4-methyl-6-ethoxycarbonyl-
2H-1,4-benzoxazine-2-acetate (17)
1
1
C12H12N2O6 e m.p.: 172 ꢁC [23]; yield (%): 39; H NMR
C16H19NO6 e m.p.: 40 ꢁC; yield (%): 35; H NMR (ppm):
(ppm): 1.25 (t, 3H, CH2COOCH2CH3, J ¼ 7.1), 3.00 (dd, 2H,
CH2COOCH2CH3), 4.20 (q, 2H, CH2COOCH2CH3), 5.00 (q,
1H, CH ), 6.80 (d, 1H, 5-H, Jm ¼ 8.7), 7.80 (m, 2H, 6-H/8-H ),
1.25 (t, 3H, CH2COOCH2CH3, J ¼ 7.2), 1.30 (t, 3H, J ¼ 7.1),
3.00 (dd, 2H, CH2COOCH2CH3), 3.45 (s, 3H, CH3), 4.25 (q,
2H, CH2COOCH2CH3, J ¼ 7.1), 4.35 (q, 2H, J ¼ 7.1), 5.00